http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021020776-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d4ad61d0af1fd483d31d1c5df9b9b76 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2020-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53aac32f2437621e94c5121caa7f50b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2898045a65fed42e6a8ef2b03daa1b3 |
| publicationDate | 2021-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2021020776-A2 |
| titleOfInvention | Use of mlc1 for diagnosis, prevention, and treatment of epilepsy and cognitive impairments associated therewith |
| abstract | The present invention relates to a novel use of MLC1 for diagnosis, prevention, and treatment of epilepsy and cognitive impairments associated therewith. As a significant increase was found in the expression level of MLC1 in the hippocampus following an early-onset seizure in a mouse model induced with an epileptic seizure, by means of the expression level of MLC1 in the hippocampus in a subject that has had an early-onset seizure, not only can epilepsy be diagnosed, but also the progression of epilepsy and cognitive impairments associated therewith can be ameliorated and treated. |
| priorityDate | 2019-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 97.